Form 8-K TScan Therapeutics, Inc. For: Aug 12
false000178332800017833282026-08-122026-08-12
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
August 12, 2026
TSCAN THERAPEUTICS, INC.
(Exact name of... (continue reading...)
Form SCHEDULE 13G/A CARMAX INC Filed by: AQR CAPITAL MANAGEMENT LLC
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 13F-HR STOREBRAND ASSET MANAGEM For: Jun 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form 8-K CYPHERPUNK TECHNOLOGIES For: Aug 12
false
0001509745
0001509745
2026-08-12
2026-08-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 Paycom Software, Inc. For: Aug 10 Filed by: Boelte Craig E.
-
Form 10-Q Protalix BioTherapeutics For: Jun 30
-
Form SCHEDULE 13G/A agilon health, inc. Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 13F-HR NORGES BANK For: Jun 30
-
Form 8-K Cycurion, Inc. For: Aug 07
-
Form 10-Q Octave Intelligence plc For: Jun 30
-
Form 6-K KAMADA LTD For: Jun 30
-
Form 8-K Fervo Energy Co For: Aug 12
-
Form 10-Q Lexeo Therapeutics, Inc. For: Jun 30
-
Form 6-K AVINO SILVER & GOLD MINE For: Aug 12
-
Form 6-K HYDRO ONE INC For: Jun 30
-
Form 6-K Hydro One Ltd For: Jun 30
-
Form 13F-HR First Beijing Investment For: Jun 30
-
Form 6-K SIMILARWEB LTD. For: Jun 30
-
Form 8-K Lexeo Therapeutics, Inc. For: Aug 12
-
Form 8-K Humacyte, Inc. For: Aug 12
-
Form 6-K Hydro One Ltd For: Jun 30
-
Form 6-K Can-Fite BioPharma Ltd. For: Aug 12
-
Form 6-K Costamare Inc. For: Aug 12
-
Form 8-K Acumen Pharmaceuticals, For: Aug 12
-
Form 8-K Octave Intelligence plc For: Aug 12
-
Form 8-K TRIMBLE INC. For: Aug 12
-
Form SCHEDULE 13G/A EDISON INTERNATIONAL Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 6-K AVINO SILVER & GOLD MINE For: Jun 30
-
Form 10-Q Milestone Pharmaceutical For: Jun 30
-
Form 8-K/A Bausch & Lomb Corp For: Aug 05
-
Form 4 Chiron Real Estate Inc. For: Aug 10 Filed by: Decker Mark Okey Jr
-
Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30
-
Form 10-Q WhiteFiber, Inc. For: Jun 30
-
Form 8-K Sound Point Meridian For: Aug 03
-
Form 8-K Performance Food Group For: Aug 12
-
Form 4 Chiron Real Estate Inc. For: Aug 10 Filed by: Fitzgerald Charles
-
Form 8-K Protalix BioTherapeutics For: Aug 12
-
Form 6-K Jumia Technologies AG For: Aug 12
-
Form 6-K Vista Energy, S.A.B. de For: Aug 12
-
Form SCHEDULE 13G/A ExlService Holdings, Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 13F-HR Turiya Advisors Asia For: Jun 30
-
Form N-CEN VIRTUS OPPORTUNITIES For: May 31
-
Form 6-K Pharvaris N.V. For: Jun 30
-
Form 6-K Cadeler A/S For: Aug 11
-
Form 8-K Kontoor Brands, Inc. For: Aug 12
-
Form 8-K T1 Energy Inc. For: Aug 12
-
Form N-PX Sharper & Granite LLC For: Jun 30
-
Form N-PX/A GRANDFIELD & DODD, LLC For: Jun 30
-
Form N-PX Breakout Capital Partner For: Jun 30
-
Form N-PX Arthur J. Gallagher & For: Jun 30
-
Form N-PX Gallagher Benefit Servic For: Jun 30
-
Form N-PX Gallagher Fiduciary Advi For: Jun 30
-
Form 10-Q Liquidia Corp For: Jun 30
-
Form N-PX Morton Capital Managemen For: Jun 30
